Deborah O. Heros

679 total citations
22 papers, 318 citations indexed

About

Deborah O. Heros is a scholar working on Genetics, Pulmonary and Respiratory Medicine and Neurology. According to data from OpenAlex, Deborah O. Heros has authored 22 papers receiving a total of 318 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Genetics, 10 papers in Pulmonary and Respiratory Medicine and 6 papers in Neurology. Recurrent topics in Deborah O. Heros's work include Glioma Diagnosis and Treatment (12 papers), Brain Metastases and Treatment (10 papers) and CNS Lymphoma Diagnosis and Treatment (3 papers). Deborah O. Heros is often cited by papers focused on Glioma Diagnosis and Treatment (12 papers), Brain Metastases and Treatment (10 papers) and CNS Lymphoma Diagnosis and Treatment (3 papers). Deborah O. Heros collaborates with scholars based in United States and Australia. Deborah O. Heros's co-authors include Ricardo J. Komotar, David L. Kasdon, Ashish H. Shah, Mison Chun, Brian E. Lally, Daniel Raper, Amadé Bregy, Stephan Wolpert, Andrew A. Maudsley and Roberto C. Heros and has published in prestigious journals such as SHILAP Revista de lepidopterología, Radiology and Neurosurgery.

In The Last Decade

Deborah O. Heros

22 papers receiving 310 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Deborah O. Heros United States 14 197 140 78 74 61 22 318
Ritu Shah United States 7 140 0.7× 113 0.8× 48 0.6× 82 1.1× 66 1.1× 18 312
Jose Bravo-Marques Portugal 7 293 1.5× 170 1.2× 54 0.7× 39 0.5× 51 0.8× 7 376
Marie Lindgren Sweden 7 330 1.7× 198 1.4× 87 1.1× 113 1.5× 46 0.8× 16 457
Ryan Zeh United States 10 224 1.1× 125 0.9× 163 2.1× 64 0.9× 47 0.8× 12 508
Kjell Watne Norway 10 150 0.8× 106 0.8× 24 0.3× 55 0.7× 34 0.6× 16 309
Alessandra Mirri Italy 9 111 0.6× 159 1.1× 40 0.5× 45 0.6× 76 1.2× 15 307
Scott Owen Canada 12 145 0.7× 248 1.8× 65 0.8× 47 0.6× 199 3.3× 41 439
Swarna Krishnasamy United States 7 190 1.0× 115 0.8× 76 1.0× 153 2.1× 29 0.5× 13 331
Lisa Chalmers United States 5 285 1.4× 153 1.1× 88 1.1× 144 1.9× 36 0.6× 12 356
Vimoj Nair Canada 11 114 0.6× 145 1.0× 52 0.7× 76 1.0× 33 0.5× 32 308

Countries citing papers authored by Deborah O. Heros

Since Specialization
Citations

This map shows the geographic impact of Deborah O. Heros's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deborah O. Heros with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deborah O. Heros more than expected).

Fields of papers citing papers by Deborah O. Heros

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Deborah O. Heros. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deborah O. Heros. The network helps show where Deborah O. Heros may publish in the future.

Co-authorship network of co-authors of Deborah O. Heros

This figure shows the co-authorship network connecting the top 25 collaborators of Deborah O. Heros. A scholar is included among the top collaborators of Deborah O. Heros based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Deborah O. Heros. Deborah O. Heros is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Saini, Vasu, et al.. (2020). Paraneoplastic Cerebellar Degeneration in Diffuse Large B-cell Lymphoma and Review of Associated Onconeural Antibodies. Clinical Lymphoma Myeloma & Leukemia. 20(6). e336–e340. 1 indexed citations
2.
Gallastegui, Nicolas, Daniel P. Cassidy, Deborah O. Heros, Francisco Vega, & Jonathan H. Schatz. (2019). Central Nervous System Involvement by Small Lymphocytic Lymphoma after a Myxoma-Related Embolic Event. SHILAP Revista de lepidopterología. 2019. 1–6. 1 indexed citations
3.
Goryawala, Mohammed, Deborah O. Heros, Ricardo J. Komotar, et al.. (2018). Value of diffusion kurtosis imaging in assessing low‐grade gliomas. Journal of Magnetic Resonance Imaging. 48(6). 1551–1558. 27 indexed citations
4.
Shah, Ashish H., Amadé Bregy, Deborah O. Heros, Ricardo J. Komotar, & Jeffrey L. Goldberg. (2013). Dendritic Cell Vaccine for Recurrent High-Grade Gliomas in Pediatric and Adult Subjects. Neurosurgery. 73(5). 863–867. 18 indexed citations
5.
Raper, Daniel, Ashish H. Shah, Amadé Bregy, et al.. (2012). The Role of Radiosurgery to the Tumor Bed After Resection of Brain Metastases. Neurosurgery. 72(3). 317–326. 61 indexed citations
6.
Shah, Ashish H., Karthik Madhavan, Deborah O. Heros, et al.. (2011). The management of incidental low-grade gliomas using magnetic resonance imaging: systematic review and optimal treatment paradigm. Neurosurgical FOCUS. 31(6). E12–E12. 21 indexed citations
7.
Feun, Lynn G., Howard J. Landy, Arnold M. Markoe, et al.. (2006). Clinical trial of CPT-11 and VM-26/VP-16 for patients with recurrent malignant brain tumors. Journal of Neuro-Oncology. 82(2). 177–181. 15 indexed citations
8.
Landy, Howard J., Arnold M. Markoe, Niramol Savaraj, et al.. (2004). Pilot Study of Estramustine Added to Radiosurgery and Radiotherapy for Treatment of High Grade Glioma. Journal of Neuro-Oncology. 67(1-2). 215–220. 8 indexed citations
9.
Vela, Lydia, George N. Sfakianakis, Deborah O. Heros, William C. Koller, & Carlos Singer. (2003). Chorea and contraceptives: Case report with pet study and review of the literature. Movement Disorders. 19(3). 349–352. 13 indexed citations
10.
Swenson, Karen K., et al.. (1997). Multifocal inflammatory leukoencephalopathy after fluorouracil and levamisole therapy for colon cancer.. American Journal of Neuroradiology. 18(8). 1591–2. 13 indexed citations
12.
Heros, Deborah O.. (1994). An Introduction to Clinical Neurology.. Neurosurgery. 35(2). 340???341–340???341. 3 indexed citations
13.
Heros, Deborah O.. (1994). An Introduction to Clinical Neurology. Neurosurgery. 35(2). 340–341. 1 indexed citations
14.
Wolpert, Stephan, et al.. (1989). Superselective arterial BCNU infusion in the treatment of patients with malignant gliomas.. American Journal of Neuroradiology. 10(4). 767–771. 13 indexed citations
15.
Chun, Mison, et al.. (1989). Interstitial iridium-192 implantation for malignant brain tumours. Part II: Clinical experience. British Journal of Radiology. 62(734). 158–162. 26 indexed citations
16.
Heros, Deborah O. & Fred H. Hochberg. (1988). Treatment of esthesioneuroblastoma with chemotherapy: A report of two cases. Journal of Neuro-Oncology. 6(2). 141–145. 12 indexed citations
17.
Wolpert, Stephan, Eddie Kwan, Deborah O. Heros, David L. Kasdon, & T. R. Hedges. (1988). Selective delivery of chemotherapeutic agents with a new catheter system.. Radiology. 166(2). 547–549. 16 indexed citations
18.
Heros, Deborah O., David L. Kasdon, & Mison Chun. (1988). Brachytherapy in the Treatment of Recurrent Solitary Brain Metastases. Neurosurgery. 23(6). 733–737. 20 indexed citations
19.
Heros, Deborah O., Kenneth L. Renkens, David L. Kasdon, & Lester S. Adelman. (1988). Patterns of recurrence in glioma patients after interstitial irradiation and chemotherapy. Neurosurgery. 22(3). 474???8–474???8. 1 indexed citations
20.
Heros, Deborah O., Kenneth L. Renkens, David L. Kasdon, & Lester S. Adelman. (1988). Patterns of Recurrence in Glioma Patients after Interstitial Irradiation and Chemotherapy: Report of Three Cases. Neurosurgery. 22(3). 474–478. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026